These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8858968)

  • 1. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians.
    Kim RB; Yamazaki H; Chiba K; O'Shea D; Mimura M; Guengerich FP; Ishizaki T; Shimada T; Wilkinson GR
    J Pharmacol Exp Ther; 1996 Oct; 279(1):4-11. PubMed ID: 8858968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of liver microsomal 7-ethoxycoumarin O-deethylation and chlorzoxazone 6-hydroxylation activities in Japanese and Caucasian subjects genotyped for CYP2E1 gene.
    Inoue K; Yamazaki H; Shimada T
    Arch Toxicol; 2000 Sep; 74(7):372-8. PubMed ID: 11043492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone.
    Marchand LL; Wilkinson GR; Wilkens LR
    Cancer Epidemiol Biomarkers Prev; 1999 Jun; 8(6):495-500. PubMed ID: 10385138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fasting and obesity in humans on the 6-hydroxylation of chlorzoxazone: a putative probe of CYP2E1 activity.
    O'Shea D; Davis SN; Kim RB; Wilkinson GR
    Clin Pharmacol Ther; 1994 Oct; 56(4):359-67. PubMed ID: 7955797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interindividual variability of chlorzoxazone 6-hydroxylation in men and women and its relationship to CYP2E1 genetic polymorphisms.
    Kim RB; O'Shea D
    Clin Pharmacol Ther; 1995 Jun; 57(6):645-55. PubMed ID: 7781264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans.
    Lucas D; Ferrara R; Gonzalez E; Bodenez P; Albores A; Manno M; Berthou F
    Pharmacogenetics; 1999 Jun; 9(3):377-88. PubMed ID: 10471070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake.
    McCarver DG; Byun R; Hines RN; Hichme M; Wegenek W
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):276-81. PubMed ID: 9772223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of CYP2E1 activity by isoniazid in rapid and slow N-acetylators.
    O'Shea D; Kim RB; Wilkinson GR
    Br J Clin Pharmacol; 1997 Jan; 43(1):99-103. PubMed ID: 9056059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cytochrome P4502E1 in human liver: assessment by mRNA, genotype and phenotype.
    Powell H; Kitteringham NR; Pirmohamed M; Smith DA; Park BK
    Pharmacogenetics; 1998 Oct; 8(5):411-21. PubMed ID: 9825833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian rhythm of cytochrome P4502E1 and its effect on disposition kinetics of chlorzoxazone in rats.
    Khemawoot P; Nishino K; Ishizaki J; Yokogawa K; Miyamoto K
    Eur J Pharmacol; 2007 Nov; 574(1):71-6. PubMed ID: 17651723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers.
    Eap CB; Schnyder C; Besson J; Savary L; Buclin T
    Clin Pharmacol Ther; 1998 Jul; 64(1):52-7. PubMed ID: 9695719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2E1 expression in human lymphocytes from various ethnic populations.
    Raucy JL; Schultz ED; Kearins MC; Arora S; Johnston DE; Omdahl JL; Eckmann L; Carpenter SP
    Alcohol Clin Exp Res; 1999 Dec; 23(12):1868-74. PubMed ID: 10630604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.
    Wang Z; Hall SD; Maya JF; Li L; Asghar A; Gorski JC
    Br J Clin Pharmacol; 2003 Jan; 55(1):77-85. PubMed ID: 12534643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 2E1 and 3A activities do not differ between Mexicans and European Americans.
    Poland RA; Lin KM; Nuccio C; Wilkinson GR
    Clin Pharmacol Ther; 2002 Sep; 72(3):288-93. PubMed ID: 12235449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive kinetic analysis and influence of reaction components for chlorzoxazone 6-hydroxylation in human liver microsomes with CYP antibodies.
    Yamamura Y; Koyama N; Umehara K
    Xenobiotica; 2015 Apr; 45(4):353-60. PubMed ID: 25815637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype.
    Carrière V; Berthou F; Baird S; Belloc C; Beaune P; de Waziers I
    Pharmacogenetics; 1996 Jun; 6(3):203-11. PubMed ID: 8807659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of human and cynomolgus monkey cytochrome P450 2E1 enzymes.
    Hanioka N; Yamamoto M; Iwabu H; Jinno H; Tanaka-Kagawa T; Naito S; Shimizu T; Masuda K; Katsu T; Narimatsu S
    Life Sci; 2007 Oct; 81(19-20):1436-45. PubMed ID: 17935737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic hypothermia-induced pharmacokinetic alterations on CYP2E1 chlorzoxazone-mediated metabolism in a cardiac arrest rat model.
    Tortorici MA; Kochanek PM; Bies RR; Poloyac SM
    Crit Care Med; 2006 Mar; 34(3):785-91. PubMed ID: 16521272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic polymorphism of human CYP2E1: new allels detected in exons and exon-intron junctions].
    Itoga S; Harada S; Nomura F; Nakai T
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1998 Feb; 33(1):56-64. PubMed ID: 9549311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine.
    Bolt HM; Roos PH; Thier R
    Int Arch Occup Environ Health; 2003 Apr; 76(3):174-85. PubMed ID: 12690492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.